Abstract
Regenerative medicine (RM) possesses the ability to repair injured as well as aging cells, tissues and organs. This review discusses the recent advances, future prospects and challenges in the field of RM mainly the stem cell therapy in degenerative retinal diseases such as age related macular degeneration (AMD), retinitis pigmentosa (RP) and Stargardt disease (STGD). Stem cell lines like retinal progenitor cells, induced pluripotent stem cells, mesenchymal stem cells, embryonic stem cells and very small embryonic-like stem cells have potential application in the degenerative retinal diseases where they have the potency to regenerate the injured and damaged photoreceptors and retinal neurons ultimately restoring and enhancing the visual functions. Stem cell transplantation for AMD, RP and STGD is currently transforming from bench side research to bedside which may eventually allow the progress of the more advanced therapies. In future, stem cell therapy could be combined with bioengineered products and small molecules to produce novel therapies in the field of ophthalmology particularly in terms of visual recovery to fight against blindness. Keywords: Age-related macular degeneration, Retinitis Pigmentosa, Regenerative Medicine, Stargardt disease, Stem Cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
